These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1107 related articles for article (PubMed ID: 23279440)

  • 1. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
    Berardelli A; Wenning GK; Antonini A; Berg D; Bloem BR; Bonifati V; Brooks D; Burn DJ; Colosimo C; Fanciulli A; Ferreira J; Gasser T; Grandas F; Kanovsky P; Kostic V; Kulisevsky J; Oertel W; Poewe W; Reese JP; Relja M; Ruzicka E; Schrag A; Seppi K; Taba P; Vidailhet M
    Eur J Neurol; 2013 Jan; 20(1):16-34. PubMed ID: 23279440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's at risk syndrome: can Parkinson's disease be predicted?
    Stern MB; Siderowf A
    Mov Disord; 2010; 25 Suppl 1():S89-93. PubMed ID: 20187248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-motor dysfunction in Parkinson's disease.
    Ziemssen T; Reichmann H
    Parkinsonism Relat Disord; 2007 Aug; 13(6):323-32. PubMed ID: 17349813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders?
    McKinnon JH; Demaerschalk BM; Caviness JN; Wellik KE; Adler CH; Wingerchuk DM
    Neurologist; 2007 Nov; 13(6):382-5. PubMed ID: 18090718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic criteria and differential diagnosis of Parkinson disease].
    Takáts A
    Ideggyogy Sz; 2003 May; 56(5-6):144-54. PubMed ID: 12861955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Parkinson's disease - why, when, and how?
    Postuma RB; Montplaisir J
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S105-9. PubMed ID: 20082967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
    Izawa MO; Miwa H; Kajimoto Y; Kondo T
    Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.
    Postuma RB; Gagnon JF; Vendette M; Montplaisir JY
    Brain; 2009 Dec; 132(Pt 12):3298-307. PubMed ID: 19843648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis of Parkinson's disease.
    Tolosa E; Wenning G; Poewe W
    Lancet Neurol; 2006 Jan; 5(1):75-86. PubMed ID: 16361025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Barton B; Grabli D; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
    Mov Disord; 2012 Feb; 27(2):248-53. PubMed ID: 22162144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of pre-motor symptoms in Parkinson's disease.
    Visanji N; Marras C
    Expert Rev Neurother; 2015 Oct; 15(10):1205-17. PubMed ID: 26416397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
    Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
    J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging in Parkinson's disease.
    Pagano G; Niccolini F; Politis M
    Clin Med (Lond); 2016 Aug; 16(4):371-5. PubMed ID: 27481384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical approach towards smell loss in Parkinson's disease.
    Haehner A; Hummel T; Reichmann H
    J Parkinsons Dis; 2014; 4(2):189-95. PubMed ID: 24322062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders.
    Bhidayasiri R; Sringean J; Reich SG; Colosimo C
    Parkinsonism Relat Disord; 2019 Feb; 59():82-92. PubMed ID: 30409560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.
    Ferreira JJ; Katzenschlager R; Bloem BR; Bonuccelli U; Burn D; Deuschl G; Dietrichs E; Fabbrini G; Friedman A; Kanovsky P; Kostic V; Nieuwboer A; Odin P; Poewe W; Rascol O; Sampaio C; Schüpbach M; Tolosa E; Trenkwalder C; Schapira A; Berardelli A; Oertel WH
    Eur J Neurol; 2013 Jan; 20(1):5-15. PubMed ID: 23279439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.